A citation-based method for searching scientific literature

Elisha Hughes, Placede Tshiaba, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Benjamin Roa, Shannon Gallagher, Stephanie Meek, Kathryn Dalton, Wade Hedegard, Carol A Adami, Danna F Grear, Susan M Domchek, Judy Garber, Johnathan M Lancaster, Jeffrey N Weitzel, Allison W Kurian, Jerry S Lanchbury, Alexander Gutin, Mark E Robson. JCO Precis Oncol 2021
Times Cited: 4







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.
Inge M M Lakeman, Mar Rodríguez-Girondo, Andrew Lee, Rikje Ruiter, Bruno H Stricker, Sara R A Wijnant, Maryam Kavousi, Antonis C Antoniou, Marjanka K Schmidt, André G Uitterlinden,[...]. Genet Med 2020
12
50

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, Andrew Lee, Penny Soucy, Joe Dennis, Susan M Domchek, Mark Robson, Amanda B Spurdle, Susan J Ramus,[...]. J Natl Cancer Inst 2017
122
50

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.
Shannon Gallagher, Elisha Hughes, Susanne Wagner, Placede Tshiaba, Eric Rosenthal, Benjamin B Roa, Allison W Kurian, Susan M Domchek, Judy Garber, Johnathan Lancaster,[...]. JAMA Netw Open 2020
30
50

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
99
50

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
267
50

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
143
50

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Leila Dorling, Sara Carvalho, Jamie Allen, Anna González-Neira, Craig Luccarini, Cecilia Wahlström, Karen A Pooley, Michael T Parsons, Cristina Fortuno, Qin Wang,[...]. N Engl J Med 2021
87
50

Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers.
Boyoung Park, John L Hopper, Aung K Win, James G Dowty, Ho Kyung Sung, Choonghyun Ahn, Sung-Won Kim, Min Hyuk Lee, Jihyoun Lee, Jong Won Lee,[...]. Oncotarget 2017
12
25

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
Nadine Andrieu, David E Goldgar, Douglas F Easton, Matti Rookus, Richard Brohet, Antonis C Antoniou, Susan Peock, Gareth Evans, Diana Eccles, Fiona Douglas,[...]. J Natl Cancer Inst 2006
126
25

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.
Angela Toss, Giovanni Grandi, Angelo Cagnacci, Luigi Marcheselli, Silvia Pavesi, Elisabetta De Matteis, Elisabetta Razzaboni, Chiara Tomasello, Stefano Cascinu, Laura Cortesi. Oncotarget 2017
16
25

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
25

A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
Yiwey Shieh, Laura Fejerman, Paul C Lott, Katie Marker, Sarah D Sawyer, Donglei Hu, Scott Huntsman, Javier Torres, Magdalena Echeverry, Mabel E Bohórquez,[...]. J Natl Cancer Inst 2020
22
25

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Marjanka K Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, Muriel A Adank, Hanne Meijers, Quinten Waisfisz, Antoinette Hollestelle, Mieke Schutte,[...]. J Clin Oncol 2016
77
25

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
309
25

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Taru A Muranen, Dario Greco, Carl Blomqvist, Kristiina Aittomäki, Sofia Khan, Frans Hogervorst, Senno Verhoef, Paul D P Pharoah, Alison M Dunning, Mitul Shah,[...]. Genet Med 2017
44
25

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Daniel R Barnes, Matti A Rookus, Lesley McGuffog, Goska Leslie, Thea M Mooij, Joe Dennis, Nasim Mavaddat, Julian Adlard, Munaza Ahmed, Kristiina Aittomäki,[...]. Genet Med 2020
28
25

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
25

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Thaddeus Judkins, Benoît Leclair, Karla Bowles, Natalia Gutin, Jeff Trost, James McCulloch, Satish Bhatnagar, Adam Murray, Jonathan Craft, Bryan Wardell,[...]. BMC Cancer 2015
72
25

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.
Elisha Hughes, Placede Tshiaba, Shannon Gallagher, Susanne Wagner, Thaddeus Judkins, Benjamin Roa, Eric Rosenthal, Susan Domchek, Judy Garber, Johnathan Lancaster,[...]. JCO Precis Oncol 2020
12
25

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
130
25

Risk-based Breast Cancer Screening: Implications of Breast Density.
Christoph I Lee, Linda E Chen, Joann G Elmore. Med Clin North Am 2017
30
25

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
184
25

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.
D G Evans, E F Harkness, S Howel, E R Woodward, A Howell, F Lalloo. Breast Cancer Res Treat 2018
4
25

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
Chi Gao, Eric C Polley, Steven N Hart, Hongyan Huang, Chunling Hu, Rohan Gnanaolivu, Jenna Lilyquist, Nicholas J Boddicker, Jie Na, Christine B Ambrosone,[...]. J Clin Oncol 2021
5
25

Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
Cong Liu, Nur Zeinomar, Wendy K Chung, Krzysztof Kiryluk, Ali G Gharavi, George Hripcsak, Katherine D Crew, Ning Shang, Atlas Khan, David Fasel,[...]. JAMA Netw Open 2021
1
100

Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers.
Guochong Jia, Yingchang Lu, Wanqing Wen, Jirong Long, Ying Liu, Ran Tao, Bingshan Li, Joshua C Denny, Xiao-Ou Shu, Wei Zheng. JNCI Cancer Spectr 2020
19
25

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
Tim Carver, Simon Hartley, Andrew Lee, Alex P Cunningham, Stephanie Archer, Chantal Babb de Villiers, Jonathan Roberts, Rod Ruston, Fiona M Walter, Marc Tischkowitz,[...]. Cancer Epidemiol Biomarkers Prev 2021
12
25

The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches.
Martin Eklund, Kristine Broglio, Christina Yau, Jason T Connor, Allison Stover Fiscalini, Laura J Esserman. JNCI Cancer Spectr 2019
11
25

The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.
Rachael Pettapiece-Phillips, Steven A Narod, Joanne Kotsopoulos. Cancer Causes Control 2015
29
25

Women's responses and understanding of polygenic breast cancer risk information.
T Yanes, R Kaur, B Meiser, M Scheepers-Joynt, S McInerny, K Barlow-Stewart, Y Antill, L Salmon, C Smyth, P A James,[...]. Fam Cancer 2020
6
25

Screening for adjustment disorders and major depressive disorders in cancer in-patients.
D Razavi, N Delvaux, C Farvacques, E Robaye. Br J Psychiatry 1990
375
25

An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients.
Juan Ignacio Arraras, Eva Greimel, Orhan Sezer, Wei-Chu Chie, Mia Bergenmar, Anna Costantini, Teresa Young, Karin Kuljanic Vlasic, Galina Velikova. Eur J Cancer 2010
108
25

Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.
Susanne F Meisel, Lindsay Sarah Macduff Fraser, Lucy Side, Sue Gessler, Katie E J Hann, Jane Wardle, Anne Lanceley. BMJ Open 2017
10
25

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Stephen S Lim, Theo Vos, Abraham D Flaxman, Goodarz Danaei, Kenji Shibuya, Heather Adair-Rohani, Markus Amann, H Ross Anderson, Kathryn G Andrews, Martin Aryee,[...]. Lancet 2012
25

How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
Angela R Bradbury, James J Dignam, Comfort N Ibe, Sogyong L Auh, Fay J Hlubocky, Shelly A Cummings, Melody White, Olufunmilayo I Olopade, Christopher K Daugherty. J Clin Oncol 2007
62
25

Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Mary-Anne Young, Laura Elenor Forrest, Victoria-Mae Rasmussen, Paul James, Gillian Mitchell, Sarah Dilys Sawyer, Katrina Reeve, Nina Hallowell. J Genet Couns 2018
18
25

Examining information-seeking behavior in genetic testing for cancer predisposition: A qualitative interview study.
Bettina M Zimmermann, Julia Fanderl, Insa Koné, Manuela Rabaglio, Nicole Bürki, David Shaw, Bernice Elger. Patient Educ Couns 2021
1
100

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Andrea Farkas Patenaude, Michel Dorval, Lisa S DiGianni, Katherine A Schneider, Anu Chittenden, Judy E Garber. J Clin Oncol 2006
123
25



Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.
Kenneth P Tercyak, Suzanne M Bronheim, Nicole Kahn, Hillary A Robertson, Bruno J Anthony, Darren Mays, Suzanne C O'Neill, Susan K Peterson, Susan Miesfeldt, Beth N Peshkin,[...]. Transl Behav Med 2019
3
33

Does family communication matter? Exploring knowledge of breast cancer genetics in cancer families.
Deborah O Himes, Sarah H Davis, Jane H Lassetter, Neil E Peterson, Margaret F Clayton, Wendy C Birmingham, Anita Y Kinney. J Community Genet 2019
3
33

Link between personality and cancer.
Alv A Dahl. Future Oncol 2010
25
25

Family communication of genetic test results among women with inherited breast cancer genes.
Deborah Cragun, Anne Weidner, Ann Tezak, Kate Clouse, Tuya Pal. J Genet Couns 2021
3
33

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Joanne Kotsopoulos, Olufunmilayo I Olopado, Parviz Ghadirian, Jan Lubinski, Henry T Lynch, Claudine Isaacs, Barbara Weber, Charmaine Kim-Sing, Peter Ainsworth, William D Foulkes,[...]. Breast Cancer Res 2005
67
25

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.
Chalanda Evans, Rebekah J Hamilton, Kenneth P Tercyak, Beth N Peshkin, Kantoniony Rabemananjara, Claudine Isaacs, Suzanne C O'Neill. Healthcare (Basel) 2016
11
25

Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
Bettina Meiser, Ben Storey, Veronica Quinn, Belinda Rahman, Lesley Andrews. J Genet Couns 2016
11
25

Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
Nathalie Alegre, Pierre Vande Perre, Yves Jean Bignon, Aude Michel, Virginie Galibert, Ornellia Mophawe, Carole Corsini, Isabelle Coupier, Jean Chiesa, Laura Robert,[...]. Psychooncology 2019
5
25

What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk?
Deborah J Bowen, Sukh Makhnoon, Brian H Shirts, Stephanie M Fullerton, Eric Larson, James D Ralston, Kathleen Leppig, David R Crosslin, David Veenstra, Gail P Jarvik. Patient Educ Couns 2021
2
50

Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.
Jean-François Morère, Jérôme Viguier, Sébastien Couraud, Lysel Brignoli-Guibaudet, Christine Lhomel, Xavier B Pivot, François Eisinger. Curr Oncol Rep 2018
7
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.